Reliv International (RELV) Given Daily News Impact Rating of 0.06
News headlines about Reliv International (NASDAQ:RELV) have trended somewhat positive on Thursday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Reliv International earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.5816094320485 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Separately, ValuEngine downgraded Reliv International from a “buy” rating to a “hold” rating in a research note on Wednesday, April 11th.
Shares of Reliv International traded down $0.06, reaching $4.69, during trading hours on Thursday, Marketbeat reports. 2,096 shares of the company’s stock were exchanged, compared to its average volume of 12,767. Reliv International has a 1 year low of $3.72 and a 1 year high of $13.77.
Reliv International Company Profile
Reliv' International, Inc develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. It offers 20 nutritional supplements, primarily, including Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form.
Receive News & Ratings for Reliv International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reliv International and related companies with MarketBeat.com's FREE daily email newsletter.